Denmark reported small growth in the number of patients accessing its medicinal cannabis pilot program early this year, but the overall market remains very small, according to data recently disclosed by the country’s official e-health portal.
New product registration underscores the limited but increasing Latin American intraregional medical cannabis trade, independent from North American cannabis production.
Clever Leaves, an international cannabis company with its main operations in Colombia, said Thursday it obtained EU-Good Manufacturing Practice certification “to produce Active Pharmaceutical Ingredients (API), semi-finished and finished cannabis products for medical purposes” in its Colombian facilities.
An analysis by a United Nations monitoring body concludes that most of the World Health Organization’s (WHO) cannabis scheduling recommendations would either have little impact on international drug controls or actually tighten requirements.
